Presentation Abstracts

* Presenting Author

13 July, 2017 - 11:00am: Session 1 - Young Investigators Symposium

  1. Development and Characterization of a Plastic Scintillating Detector for Small Animal Irradiators
    Chris Johnstone* (University of Victoria), Chris Johnstone (University of Victoria), Luc Beaulieu ( Université Laval), Francois Therriault-Proulx (CHU de Quebec et CHUM), Magdalena Bazalova-Carter (University of Victoria)
  2. Examination of dosimetric properties of a colloidal quantum dot-based liquid scintillator
    Marie-Ève Delage* (CHU de Québec - Université Laval), Marie-Ève Delage (CHU de Québec - Université Laval), Marie-Ève Lecavalier (Département de chimie, Université Laval), Dominic Larivière (Département de chimie, Université Laval), Claudine Allen (Centre d'optique photonique et laser, Université Laval), Luc Beaulieu (CHU de Québec - Université Laval)
  3. Alternative geometries for x-ray fluorescence CT (XFCT) imaging of gold nanoparticles
    Chelsea Dunning* (University of Victoria), Chelsea Dunning (University of Victoria), Magdalena Bazalova-Carter (University of Victoria)
  4. Cherenkov dosimetry via directional Cherenkov-to-dose conversion factors: Monte Carlo protocol and experimental feasibility
    Yana Zlateva* (McGill University), Yana Zlateva (McGill University), Jan Seuntjens (Cedars Cancer Centre), Issam El Naqa (University of Michigan)
  5. An intensity modulated delivery system for prostate brachytherapy using intermediate energy sources
    Gabriel Famulari* (McGill University), Gabriel Famulari (McGill University), Marc-Andre Renaud (McGill University), Shirin Enger (McGill University)
  6. Development of an Advanced 2-D THGEM Detector and Multi-Input Digital Signal Processor System for the Measurement of Dose Distribution in Low and High LET Mixed Radiation Fields
    Sahar Darvish-Molla* (McMaster University), Sahar Darvish-Molla (McMaster University), Soo Hyun Byun (McMaster University), Kenrick Chin (McMaster University), William V. Prestwich (McMaster University)
  7. Investigating energy deposition in glandular tissues for mammography using multiscale Monte Carlo simulations
    Patricia Oliver* (Carleton University), Rowan Thomson (Carleton University)
  8. Is it noise or abnormality? A method for estimating local noise in a CZT SPECT camera
    Sarah G. Cuddy-Walsh* (Carleton University), Sarah G. Cuddy-Walsh (Carleton University), R. Glenn Wells (University of Ottawa Heart Institute, University of Ottawa)
  9. Introduction of a Deformable X-ray CT Polymer Gel Dosimetry System
    Evan Maynard* (University of Victoria), Evan Maynard (1) ((1) Department of Physics and Astronomy, University of Victoria), Emily Heath (2) ((2) Carleton Laboratory for Radiotherapy Physics, Department of Physics, Carleton University), Michelle Hilts (3)(4) ((3) Department of Physics, University of British Columbia Okanagan, (4) Medical Physics, BC Cancer Agency, Centre for the Southern Interior), Andrew Jirasek (5) ((5) Department of Physics, I.K. Barber School of Arts and Sciences, University of British Columbia)
  10. Ion chamber quality and magnetic field conversion factors and angular dependence in magnetic fields
    Victor Malkov* (Carleton University), Victor Malkov (Carleton University), David W.O. Rogers (Carleton University)

13 July, 2017 - 2:30pm: Session 2 - Highlight Session

  1. Novel methodology for applying radiomics to small datasets
    Avishek Chatterjee* (McGill University Health Centre), Avishek Chatterjee (McGill University Health Centre), Martin Vallières (McGill University Health Centre), Anthony Dohan (McGill University Health Centre), Ives Levesque (McGill University Health Centre), Yoshiko Ueno (Kobe University), Vipul Bist (Venkateshwar Hospital), Sameh Saif (McGill University Health Centre), Caroline Reinhold (McGill University Health Centre), Jan Seuntjens (McGill University Health Centre)
  2. Augmenting physicist review of pre-treatment verification measurements with machine learning
    Dal Granville* (The Ottawa Hospital), Dal Granville (The Ottawa Hospital), Justin Sutherland (The Ottawa Hospital), Daniel La Russa (The Ottawa Hospital)
  3. Quality Assurance for 3D Printing in Radiation Therapy
    David Sasaki* (CancerCare Manitoba), David Sasaki (CancerCare Manitoba), Philip McGeachy (CancerCare Manitoba), Daniel W Rickey (CancerCare Manitoba), Chad Harris (CancerCare Manitoba), Eric VanUytven (CancerCare Manitoba), Arbind Dubey (CancerCare Manitoba)
  4. Need for Power quality QA - Based on a case study at Walker Family Cancer Centre
    Josef Dubicki* (Hamilton Health Sciences), Ranjini Tolakanahalli (Hamilton Health Sciences), Josef Dubicki (Hamilton Health Sciences), William Wyatt (Johnsons Control), Ady Abdellatif (Walker Family Cancer Centre)
  5. The new radionuclide source model in EGSnrc
    Reid Townson* (Measurement Science and Standards, National Research Council Canada), Reid Townson (Measurement Science and Standards, National Research Council Canada), Frédéric Tessier (Measurement Science and Standards, National Research Council Canada), Raphael Galea (Measurement Science and Standards, National Research Council Canada)
  6. Investigation of Real-Time Interactive Planning Efficiency and Plan Quality for Head and Neck VMAT
    Quinn Matthews* (BC Cancer Agency - Centre for the North), Quinn Matthews (BC Cancer Agency - Centre for the North), Lindsey Baker (BC Cancer Agency - Centre for the North), Taran Braich (BC Cancer Agency - Centre for the North), Allison Ye (BC Cancer Agency - Centre for the North), Theodora Koulis (BC Cancer Agency - Centre for the North), Eric Tran (BC Cancer Agency - Vancouver Centre), Nisar Ahmed (BC Cancer Agency - Abbotsford Centre), Sally Smith (BC Cancer Agency - Vancouver Island Centre), Ante Mestrovic (BC Cancer Agency - Vancouver Centre), Karl Otto (N/A), Robert Olson (BC Cancer Agency - Centre for the North)
  7. Automated linac, MLC, and patient QA using an EPID
    Peter McCowan* (CancerCare Manitoba), Peter McCowan (CancerCare Manitoba), Timothy vanBeek (CancerCare Manitoba), Eirc vanUytven (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba)
  8. A comprehensive quality assurance program for a radiation treatment couchtop with six degrees of freedom
    Balazs Nyiri* (The Ottawa Hospital Cancer Centre), Balazs Nyiri (The Ottawa Hospital Cancer Centre), Elsayed Ali (The Ottawa Hospital Cancer Centre)
  9. A decision-support tool for prediction of dosimetric eligibility and triage of treatment planning difficulty for hypofractionated prostate radiotherapy.
    Anthony Lausch* (Department of Radiation Oncology, University of Toronto), Anthony Lausch (Department of Radiation Oncology, University of Toronto, Toronto, Canada;), Michael Lamey (Carlo Fidani Peel Regional Cancer Centre, Trillium Health Partners, Mississauga, Canada), Grace Zeng-Harpell

13 July, 2017 - 4:00pm: Session 3 - Quality and Safety

  1. Managing Equipment Downtime: Standardized Definitions and Data Structure For Linac Service Event Reporting
    Michael Lamey* (Trillium Health Partners), Crystal Angers (The Ottawa Hospital), Leslie Buckley (The Ottawa Hospital), Michael Lamey (Trillium Health Partners), Scott Karnas (London Regional Cancer Program/LHSC), Erin Barnett (Stronach Regional Cancer Centre), Josh Gaul (Windsor Regional Hospital), Runqing Jiang (Grand River Regional Cancer Centre), Miller MacPherson (The Ottawa Hospital), Patrick Rapley (Thunder Bay Regional HS Ctr), Jeff Richer (Windsor Regional Hospital), Luc Serre (Windsor Regional Hospital), Shuying Wang (Northeast Cancer Center), Michael Sharpe (Princess Margaret Hospital -UHN), Stephen Breen (Princess Margaret Hospital -UHN), Carina Simniceanu (Cancer Care Ontario)
  2. An interprofessional approach to the standardization of a quality assurance program in medical imaging using QATrack+
    Lesley Buckley* (The Ottawa Hospital Cancer Centre), Imran Juma (The Ottawa Hospital Dept of Medical Imaging), Lesley Buckley (The Ottawa Hospital Cancer Centre), Alan Thibeau (The Ottawa Hospital Dept of Medical Imaging), Gary Heddon (The Ottawa Hospital Dept of Medical Imaging), Ian Byrne (The Ottawa Hospital Dept of Medical Imaging), Ryan Bottema (The Ottawa Hospital Cancer Centre), Crystal Plume Angers (The Ottawa Hospital Cancer Centre)
  3. Variability in Lung SBRT Contours and Doses at Canadian Institutions
    Marcin Wierzbicki* (Juravinski Cancer Centre), Marcin Wierzbicki (Juravinski Cancer Centre), Anand Swaminath (Juravinski Cancer Centre)
  4. Maintaining the Canadian Biodosimetry Network
    Ruth Wilkins* (Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, ON), Ruth Wilkins (Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, ON), Sylvie Lachapelle, Barbara Kutzner, Lindsay Beaton-Green
  5. Different treatment planning system algorithms show different accuracies in the IROC lung phantom: updated results
    Stephen Kry* (UT MD Anderson Cancer Centre), Stephen Kry (UT MD Anderson Cancer Centre), Andrea Molineu (UT MD Anderson Cancer Center), Paola Alvarez (UT MD Anderson Cancer Center), David Followill (UT MD Anderson Cancer Center)
  6. Feasibility of using Truebeam Linac Log Files for Informed Radiation Safety Related Parameters in the VMAT era of External Beam Radiation Therapy
    Michael Lamey* (Trillium Health Partners), Michael Lamey (Trillium Health Partners), Merle Robertson (Juravinski Cancer Centre), Raxa Sankreacha (Trillium Health Partners)

13 July, 2017 - 6:30pm: Poster Reception

  1. Shielding calculations and radiation survey of a Vero SBRT unit in an existing treatment room
    Marc Chamberland* (BC Cancer Agency), Marc Chamberland (BC Cancer Agency - Vancouver Cancer Centre), M. Peter Petric (BC Cancer Agency - Vancouver Cancer Centre), Sheila MacMahon (BC Cancer Agency - Vancouver Cancer Centre), Eman Khawandanh (Saudi Arabian Cultural Bureau and National Guard Health Affairs), Shadi Chitsazzadeh (British Columbia Cencer Agency - Vancouver Island)
  2. Recommendations for Dosimetric Commissioning of Proton Therapy for Iris Melanoma
    Cheryl Duzenli* (BC Cancer Agency-Vancouver), Cheryl Duzenli (BC Cancer Agency-Vancouver), Joel Beaudry (BC Cancer Agency-Vancouver), Clay Lindsay (University of Victoria), Richard Lee (BC Cancer Agency-Vancouver), Crystal Penner (University of British Columbia), Vince Strgar (BC Cancer Agency-Vancouver), Cornelia Hoehr (TRIUMF)
  3. Retrospective study of the PTV margin impact for lung SBRT
    Malik Brunet-Benkhoucha* (Hôpital Maisonneuve-Rosemont), Christophe Furstoss (Hôpital Maisonneuve-Rosemont), Anthony Bartoli, Malik Brunet-Benkhoucha, Alexis Bujold
  4. Experimental determination of the dose rate constant for an Ir-192 HDR source
    Islam El Gamal* (National Research Council Canada), Islam El Gamal (National Research Council Canada), Claudiu Cojocaru, Ernesto Mainegra-Hing, Malcolm McEwen, Brad Downton
  5. MR-safe personal radiation dosimeters
    Ekaterina Tchistiakova* (Sunnybrook Health Sciences Centre / Odette Cancer Centre, Toronto, ON, Canada), Ekaterina Tchistiakova (Sunnybrook Health Sciences Centre / Odette Cancer Centre, Toronto, ON, Canada), Anthony Kim, William Song, Geordi Pang
  6. Investigating different iterative metal artifact reduction (iMAR) algorithms for a SIEMENS SOMATOM Definition Edge CT scanner
    Philip McGeachy* (CancerCare Manitoba), Philip McGeachy (CancerCare Manitoba), David Sasaki (CancerCare Manitoba)
  7. Transferring VMAT plans between Clinac iX and TrueBeam linacs
    Marie-Pierre Milette* (BC Cancer Agency-Southern Interior), Marie-Pierre Milette (1) ((1) BC Cancer Agency-Southern Interior), Leo Sporn (1), John Wolters (1), Tony Teke (1)
  8. Does Respiratory Gating Improve the Quality of Magnetic Resonance Spectra Acquired from Spinal Bone Marrow?
    Atiyah Yahya* (Cross Cancer Institute and University of Alberta), Marissa Fisher (University of Alberta), Atiyah Yahya (Cross Cancer Institute and University of Alberta)
  9. Quantifying the dosimetric impact on VMAT plans due to variations in CT simulator CT-to-ED calibration curves
    Nelson Miksys* (The Ottawa Hospital Cancer Centre), Nelson Miksys (The Ottawa Hospital Cancer Centre), Dal Granville (The Ottawa Hospital Cancer Centre), Lesley Buckley (The Ottawa Hospital Cancer Centre)
  10. Eliminating the high density diode array measurement for stereotactic VMAT plan verifications
    Cynthia Araujo* (BC Cancer Agency-Southern Interior), Derek Hyde (BC Cancer Agency-Southern Interior), Marie-Pierre Milette (BC Cancer Agency-Southern Interior), Tony Teke (BC Cancer Agency-Southern Interior), Claude Lapointe (BC Cancer Agency-Southern Interior)
  11. The use of a flat-panel detector for seven-beam x-ray coherent scatter imaging
    Paul C. Johns* (Carleton University), Kelly A. Foran¹ (¹Dept. of Physics, Mount Allison University, Sackville, New Brunswick), Paul C. Johns² (²Dept. of Physics, Carleton University, Ottawa, Ontario, Canada)
  12. Two methods for the display of coherent x-ray scatter projection images
    Christopher Dydula* (Carleton University), Shuhang Chen¹ (¹College of Optical Science and Engineering, Zhejiang University, Hangzhou, China), Christopher Dydula² (²Dept. of Physics, Carleton University, Ottawa, Canada), Paul C. Johns²
  13. Implementation of a web-based tracking tool for interventions on linear accelerators
    Stanislas Nicol* (Hôpital Maisonneuve-Rosemont), Stanislas Nicol (Hôpital Maisonneuve-Rosemont), Laurie Archambault*, Patrice Munger, Vincent Leduc, Wieslaw Wierzbicki
  14. The effect of MLC positioning errors on plan dose distribution and gamma analysis using EPID dosimetry
    Ernest Osei* (Grand River Regional Cancer Centre), Borna Maraghechi (Grand River Regional Cancer Centre), Jack Davis (University of Waterloo), Nicholas Mitchell (University of Waterloo), Meera Shah (University of Waterloo), Andre Fleck (Grand River Regional Cancer Centre), Johnson Darko (Grand River Regional Cancer Centre), Ernest Osei (Grand River Regional Cancer Centre)
  15. Detection And Tracking of Multiple Targets on Portal Images Using Feature-Based Learning and Weighted Optical Flow
    Kaiming Guo* (CancerCare Manitoba), Kaiming Guo (CancerCare Manitoba), Troy P.T. Teo (CancerCare Manitoba), Yang Wang (Department of Computer Science, University of Manitoba), Stephen Pistorius (CancerCare Manitoba)
  16. X-ray scatter projection imaging of an ex vivo canine prostate
    Christopher Dydula* (Carleton University), Christopher Dydula (Dept. of Physics, Carleton University, Ottawa, Canada), Paul C. Johns
  17. Use of Tessellated Geometry for Improved Linac Design and Modeling in Monte Carlo Simulations
    Rao Khan* (Washington University in St. Louis School of Medicine), Rao Khan (Washington University in St. Louis School of Medicine), Praneeth Kandlakunta, Tiezhi Zhang
  18. Investigating flattening filter free mode for peripheral lung stereotactic body radiation therapy
    Michael Jensen* (R. S. McLaughlin Durham Regional Cancer Centre / Lakeridge Health), Michael Jensen (R. S. McLaughlin Durham Regional Cancer Centre / Lakeridge Health), Lourdes M. Garcia (R. S. McLaughlin Durham Regional Cancer Centre / Lakeridge Health), Daryl Scora (R. S. McLaughlin Durham Regional Cancer Centre / Lakeridge Health), Aaron Vandermeer (R. S. McLaughlin Durham Regional Cancer Centre / Lakeridge Health)
  19. Inter-observer Variability in Structure Delineation of Organs at Risk on Cone Beam CT using RayStation Treatment Planning System v4.5.2
    Andrea McNiven* (Princess Margaret Cancer Centre - UHN), Olive Wong, Andrea McNiven (Princess Margaret Cancer Centre - UHN), Biu Chan, Jenny Lee, Joanne Moseley, Cijian Ren (University of Toronto), Scott Bratman, Andrew Hope, Jean-Pierre Bissonnette, John Waldron, Beibei Zhang, Meredith Giuliani
  20. Development and validation of a Monte Carlo tool for analysis of patient-generated photon scatter
    Kaiming Guo* (CancerCare Manitoba), Kaiming Guo (CancerCare Manitoba), Harry Ingleby (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba)
  21. Verification of photon total body irradiation using the IROC-Houston anthropomorphic phantom
    Michael D. C. Evans* (McGill University Health Centre), Michael D. C. Evans (McGill University Health Centre), Russell Ruo (McGill University Health Centre), Christine Hudon (McGill University Health Centre), Ciro Maietta (McGill University Health Centre), Andrea Molineu (IROC-Houston, UT MD Anderson Cancer Center), Hunter Mehrens (IROC-Houston, UT MD Anderson Cancer Center), William Parker (McGill University Health Centre), Suzanne Rossel (McGill University Health Centre)
  22. Minimal Transformation Sequences in Image Orientation for Proton Therapy
    Richard Lee* (BC Cancer Agency), Richard Lee (BC Cancer Agency), Steven Thomas (BC Cancer Agency), Robert Kosztyla (BC Cancer Agency), Roy Ma (BC Cancer Agency), Katerine Paton (Dept of Opthalmology and Visual Sciences, Faculty of Medicine, UBC)
  23. An adaptive total variation method applied to the CT image reconstruction
    Heping Xu* (Nova Scotia Health Authority), Shaohua Chen (Cape Breton University), Heping Xu (Dalhousie University and Nova Scotia Health Authority)
  24. Raystation KV cone-beam CT radiotherapy dose calculation: toward clinical dose tracking
    Jonatan Snir* (London Regional Cancer Program), Jonatan Snir (London Regional Cancer Program), Donna Murrell (London Regional Cancer Program), Hatim Fakir (London Regional Cancer Program)
  25. A dosimetric study of linac-based gated SBRT using FFF and standard 6MV beams
    Adam Blais* (Juravinski Cancer Centre), Adam Blais (Juravinski Cancer Centre), Janos Juhasz (Juravinski Cancer Centre), Martin Shim (Juravinski Cancer Centre), Marcin Wierzbicki (Juravinski Cancer Centre), Roxana Vlad (Juravinski Cancer Centre)
  26. Shielding of high strength static magnetic fields for conventional radiation survey meters
    Geordi Pang* (Odette Cancer Centre), Kevin Wang, Geordi Pang (Odette Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, Canada)
  27. Use of Rotational Beam Evaluation During Acceptance and Commissioning of a Medical Linear Accelerator
    Jason Hancock* (Alberta Health Services), Jason Hancock (Alberta Health Services)
  28. In-vivo Dose Verification of SBRT-VMAT Treatment Delivery using Transmission EPID Images with 4DCT Datasets
    Sajjad Aftabi* (University of Manitoba / CancerCare Manitoba), Sajjad Aftabi (University of Manitoba / CancerCare Manitoba), Sankaranarayanan Venkataraman (CancerCare Manitoba), Timothy VanBeek (CancerCare Manitoba), Philip McGeachy (CancerCare Manitoba), Peter McCowan (CancerCare Manitoba), Stephen Pistorius (University of Manitoba / CancerCare Manitoba), Boyd McCurdy (University of Manitoba / CancerCare Manitoba)
  29. Evaluation of the Dose Response of an Organic Thin Film Transistor in Radiation Fields of Different Qualities
    Michael Hupman* (Department of Medical Physics, Dalhousie University), Michael Hupman (Department of Medical Physics, Dalhousie University), Ian Hill (Department of Physics and Atmospheric Science, Dalhousie University), Alasdair Syme (Department of Medical Physics, Nova Scotia Health Authority)
  30. Retrospective analysis of daily positional variations of the metal port of breast tissue expanders for post mastectomy patients treated on Tomotherapy
    Elsayed Ali* (The Ottawa Hospital Cancer Centre), Cayliegh Martell (The Ottawa Hospital Cancer Centre), Jamie Bahm (The Ottawa Hospital Cancer Centre), Elsayed Ali (The Ottawa Hospital Cancer Centre)
  31. Positional and directional accuracy in the placement of I-125 seeds in permanent prostate brachytherapy implants
    Maryam Afsari Golshan* (BC Cancer Agency), Maryam Afsari Golshan (BC Cancer Agency), Ingrid Spadinger (BC Cancer Agency-Vancouver), Sara Mahdavi (BC Cancer Agency-Vancouver)
  32. Radiation biodosimetry with the Cytokinesis-Block Micronucleus assay on the ImageStreamX® imaging flow cytometer
    Lindsay Beaton-Green* (Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 1C1, Canada), Lindsay A. Beaton-Green (Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 1C1, Canada), Matthew A. Rodrigues (Amnis®, a part of MilliporeSigma, 645 Elliott Avenue West, Suite 100, Seattle, WA 98119, USA), Ruth C. Wilkins (Health Canada)
  33. Permanent Breast Seed Implants Observed Immediately and One Month Following Implant
    Michelle Hilts* ((1)Medical Physics, BC Cancer Agency - Southern Interior), Michelle Hilts(1)(2)(3) ((1)Medical Physics, BC Cancer Agency - Southern Interior), Cassidy Northway(1)(2) ((2)Department of Physics, University of British Columbia Okanagan), Deidre Batchelar(1)(2), Daniel Morton(1)(3) ((3)Department of Physics, University of Victoria), Marie-Pierre Milette(1)(2), Juanita Crook(1)
  34. Beyond the Modified Kersey's Method
    Adam Dodd* (CSNC), Kevin Shimotakahara (CNSC)
  35. Personalized PTV margins for prostate cancer patients using a machine-learning approach
    Andrew Coathup* (University of Victoria), Andrew Coathup (University of Victoria), Parminder Basran (BCCA-Vancouver Island Centre)
  36. Emulation of banding artifacts when predicting EPID image frame sequences
    Parandoush Abbasian* (CancerCare Manitoba), Parandoush Abbasian (CancerCare Manitoba), Peter McCowan (CancerCare Manitoba), Daniel Rickey (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba)
  37. Dosimetric evaluation of the Acuros XB (AXB) algorithm for 6FFF and 10FFF photon beams in head & neck and stereotactic brain VMAT radiation therapy
    Sepideh Behinaein* (Grand River Hospital), Sepideh Behinaein (Grand River Hospital), Paule Charland (Grand River Regional Cancer Centre), Ernest Osei (Grand River Regional Cancer Centre)
  38. The value of 3D ultrasound in permanent breast seed implant brachytherapy
    Michelle Hilts* (BC Cancer Agency), Daniel Morton (BC Cancer Agency - CCSI, University of Victoria), Justin Michael (Robarts Research Institute, Western University), Deidre Batchelar (University of British Columbia), Michelle Hilts, Aaron Fenster, Juanita Crook
  39. Effect of translational and rotational errors on the accuracy of CyberKnife liver treatments
    Ming Liu* (Carleton University), Ming Liu (*Carleton University), Eric Vandervoort†* (†The Ottawa Hospital Cancer Centre), Joanna Cygler†*
  40. Development of a Realistic Phantom for MR-only Treatment Planning in the Brain
    Brige Chugh* (Sunnybrook Health Sciences Centre), Brige Chugh (Sunnybrook Health Sciences Centre), Abraam Soliman (Sunnybrook Health Sciences Centre), Young Lee (Sunnybrook Health Sciences Centre), Justin Y.C. Lau (Sunnybrook Health Sciences Centre), Chia-Lin Tseng (Sunnybrook Health Sciences Centre), Arjun Sahgal (Sunnybrook Health Sciences Centre), Greg Stanisz (Sunnybrook Health Sciences Centre), Angus Lau (Sunnybrook Health Sciences Centre)
  41. Laser source compensator for optical CT imaging of gel dosimeters
    Kurtis Dekker* (The University of Western Ontario), Kurtis Dekker (The University of Western Ontario), Jerry Battista (The University of Western Ontario), Kevin Jordan (London Regional Cancer Program/LHSC)
  42. Accurate geometric calibration of linac-mounted cone beam CT systems
    Matt Hemsley* (Carleton University), Matt Hemsley (Carleton University), Elsayed Ali (The Ottawa Hospital Cancer Centre), Rolf Clackdoyle (Université Grenoble Alpes), Tong Xu (Carleton University)
  43. Influence of three calibration methods of EBT-XD GAFChromic Film for the dosimetric verification of SRS plans
    Amjad Hussain* (Western Manitoba Cancer Centre), Amjad Hussain (Western Manitoba Cancer Centre), Alana Hudson (Tom Baker Cancer Centre), Wazir Muhammad (PINSTECH), Nicolas Ploquine (Tom Baker Cancer Centre)
  44. Validation of standard plan libraries and retrospective analysis of reconstruction techniques in vaginal vault brachytherapy for postoperative endometrial cancer
    Yuji Kamio* (CHUM Notre Dame Hospital), Yuji Kamio (CHUM Notre Dame Hospital)
  45. Monte Carlo dose calculations for permanent breast seed implant brachytherapy
    Stephen Deering* (Carleton University), Stephen Deering (Carleton University), Rowan Thomson (Carleton University), Michelle Hilts (BCCA-CSI), Daniel Morton (BC Cancer Agency), Deidre Batchelar (Centre for the Southern Interior), Marie-Pierre Milette (BC Cancer Agency-Southern Interior)
  46. Large scale comparison between AAA and MC-recalculated lung SBRT cases
    André Diamant* (McGill University), André Diamant (McGill University), Marc-André Renaud (McGill University), Jan Seuntjens (Cedars Cancer Centre)
  47. Optimization and experimental characterization of a 3 points plastic scintillator dosimeter
    Luc Beaulieu* (CHU de Quebec-Université Laval), Haydee Maria Linares Rosales (CHU de Quebec-Université Laval), Louis Archambault (CHU de Quebec-Université Laval), Sam Beddar (MD Anderson Cancer Center), Luc Beaulieu (CHU de Quebec-Université Laval)
  48. Characterization of OSLD reproducibility with number of repeated reads
    Emmanuel Osunkwor* (McGill University), Emmanuel Osunkwor (McGill University), Khushdeep Singh (McGill University Health Centre), Jan Seuntjens (McGill University), Stephen Davis (McGill University Health Centre)
  49. The application of Raman Spectroscopy for in vitro dose discrimination of human lens epithelial cells exposed to ionizing radiation
    Christian Harry Allen* (Carleton University), Christian Harry Allen (Carleton University), Achint Kumar (Carleton University), Christopher Dedek (Carleton University), Hamid Moradi (Carleton University), Abrar Ahmad (Carleton University), Vinita Chauhan (Health Canada), Balazs Nyiri (The Ottawa Hospital ), Sangeeta Murugkar (Carleton University)
  50. Respiratory motion prediction using multi-output Gaussian process regression
    Azeez Omotayo* (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba), Sankar Venkataraman (CancerCare Manitoba)
  51. Verification for small fields of a 6 MV FFF beam model of a Varian EDGE accelerator
    Congwu Cui* (Saint John Regional Hospital / Horizon Health Network / Dalhousie University), Congwu Cui (Saint John Regional Hospital / Horizon Health Network / Dalhousie University), Zhengfeng Liu (Saint John Regional Hospital / Horizon Health Network ), Pierre Therrien (Saint John Regional Hospital / Horizon Health Network )
  52. Pd-103 and I-125 Dose Comparison for Delivered Ocular Brachytherapy Plans
    Matthew Larocque* (University of Alberta), Matthew Larocque (University of Alberta), Ezekiel Weis (University of Alberta), Geetha Menon (University of Alberta)
  53. Comparison of Eye Geometry Measurement Methods for Ocular Brachytherapy
    Matthew Larocque* (University of Alberta), Matthew Larocque (University of Alberta), Hali Morrison (University of Alberta), Ezekiel Weis (University of Alberta)
  54. Penumbra softener of EDW side borders for improved control of junction inhomogeneities in four-field monoisocentric breast plans
    Stanley Szpala* (BCCA-Fraser Valley Centre), Stanley Szpala (BCCA-Fraser Valley Centre), Kirpal S.Kirpal Kohli (BCCA-Fraser Valley Centre)
  55. Implementation of a voluntary breath-hold technique using Philips bellows with an in-house software
    Caroline Duchesne* (Hôpital Maisonneuve-Rosemont), Caroline Duchesne (Hôpital Maisonneuve-Rosemont), Etienne Roussin, Simon Péloquin (University of Montreal), Maryse Bernard, Eveline L Masse, Elisabel Morin, Julie St-Pierre, Brigitte Trudeau
  56. A Quality Control system to automatically detect errors and identify features in radiotherapy treatment plans.
    Michael Balderson* (Princes Margaret Cancer Centre), Michael Balderson (Princes Margaret Cancer Centre), Chris McIntosh (Princess Margaret Cancer Centre, TECHNA Institute), Thomas Purdie (Princess Margaret Hospital -UHN)
  57. Incorporating mpMRI into US-based treatment planning for prostate brachytherapy: A real world solution
    Deidre Batchelar* (BC Cancer Agency - Southern Interior), Deidre Batchelar(1,2) ((1)BC Cancer Agency - Southern Interior), Cynthia Araujo(1,2) ((2)Department of Physics, University of British Columbia - Okanagan), Matthew G. Schmid(1,2), Michelle Hilts(1,2), Martin Korzeniowski(1), Laurie Pilote(1), Francois Bachand(1), Juanita Crook(1)
  58. Dependence of a commercial electron beam macro Monte Carlo model to physical density variations
    Rao Khan* (Washington University School of Medicine, Washington University in St Louis, St Louis, MO, USA), Thomas Mazur, Douglas Bollinger, Sasa Mutic, Sreekrishna Goddu, Michael Reilly, Rao Khan (Washington University School of Medicine, Washington University in St Louis, St Louis, MO, USA)
  59. Inverse Optimization of Low-Cost Kilovoltage Arc Therapy Plans for Breast and Lung Patients
    Dylan Breitkreutz* (University of Victoria), Dylan Breitkreutz (University of Victoria), Marc-Andre Renaud (McGill University), Micheal Weil (Sirius Medicine LLC), Jan Seuntjeuns (McGill University), Magdalena Bazalova-Carter (University of Victoria)
  60. Deep Inspiration Breath Hold for Breast: New Sources of Uncertainty and their Impact on Treatment
    Leigh Conroy* (University of Calgary), Leigh Conroy (University of Calgary), Sarah Quirk (University of Calgary), Elizabeth Watt (University of Calgary), Gillian Ecclestone (Tom Baker Cancer Centre), Jessica Conway (University of Calgary), Tien Phan (University of Calgary), Wendy Smith (University of Calgary)
  61. Improving bladder sparing in VMAT-treated prostate cancer with stochastic frontier analysis
    Angelika Kroshko* (Université Laval), Angelika Kroshko (CHU de Québec - Université Laval), Nicolas Varfalvy (CHU de Québec - Université Laval), Olivier Morin (University of California), Louis Archambault (CHU de Québec - Université Laval)
  62. Optimization of Simple Flagging Metrics to Identify Adaptive Radiation Therapy Candidates
    Wendy Smith* (Tom Baker Cancer Centre), Sarah Weppler (University of Calgary), Harvey Quon (Tom Baker Cancer Centre), Robyn Banerjee (Tom Baker Cancer Centre), Colleen Schinkel (Tom Baker Cancer Centre), Wendy Smith (Tom Baker Cancer Centre)
  63. Emergency simulations in HDR brachytherapy: CHU de Québec – Université Laval’s 3 year experience
    Nadia Octave* (CHU de Québec - Université Laval), Nadia Octave (CHU de Québec - Université Laval), Janelle Morrier (CHU de Québec - Université Laval), Jonathan Boivin (CHU de Québec - Université Laval), Mario Chrétien (CHU de Québec - Université Laval)
  64. Internal Dosimetry of a Novel Y-90 Glass Microsphere in Transarterial Radioembolization
    E. Courtney Henry* (Dept of Physics and Atmospheric Science, Dalhousie University), E. Courtney Henry (Dept of Physics and Atmospheric Science, Dalhousie University), George Mawko (Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada), Robert Lewandowski (Interventional Radiology, Northwestern University, Chicago, IL/US), David Liu (Vancouver Imaging, Clinical Associate Professor, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada), Sharon Kehoe (Department of Applied Oral Sciences, Dalhousie University, Halifax, Nova Scotia, Canada), Daniel Boyd (Department of Applied Oral Sciences, Dalhousie University, Halifax, Nova Scotia, Canada), Robert Abraham (Department of Diagnostic Imaging, Dalhousie University, Halifax, Nova Scotia, Canada), Alasdair Syme (Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada)
  65. Moving from a 3-field 3D technique to IMRT for lung treatment planning
    Matthieu Lemire* (Hôpital Maisonneuve-Rosemont), Matthieu Lemire (Hôpital Maisonneuve-Rosemont), Étienne Roussin (Hôpital Maisonneuve-Rosemont), Stéphane Généreux (Hôpital Maisonneuve-Rosemont), Maxime Lachance (Hôpital Maisonneuve-Rosemont)
  66. Professional Liability Insurance Options for Qualified Medical Physicists
    Jeff Frimeth* (JF Medical Physics Inc.), Jeff Frimeth (JF Medical Physics Inc.), David Jordan (University Hospitals Cleveland Medical Center)
  67. Dosimetric Comparison between Single IMRT Field and Multiple IMRT Fields Technique for Use in Craniospinal Irradiation (CSI)
    David Sasaki* (CancerCare Manitoba), Suliman Barhoum (Department of Physics & Astronomy/ University of Manitoba), David Sasaki (CancerCare Manitoba), Pam Brechin (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba)
  68. Effects of the dosimetric leaf gap in treatment planning system on the agreement between predicted and measured doses
    Congwu Cui* (Saint John Regional Hospital / Horizon Health Network), Congwu Cui (Saint John Regional Hospital / Horizon Health Network / Dalhousie University), Xia Wu (Trillium Health Partners / Credit Valley Hospital Site)
  69. Trials and triumphs of vintage linac ownership: A cost benefit analysis
    David Spencer* (Tom Baker Cancer Centre), Alana Hudson (Tom Baker Cancer Centre), Nathan Edmonds (Tom Baker Cancer Centre), David Spencer (Tom Baker Cancer Centre), Gosia D'Souza (Tom Baker Cancer Centre), Rahim Heshmati (Tom Baker Cancer Centre), Greg Pierce (Tom Baker Cancer Centre)

14 July, 2017 - 11:00am: Session 4A - Radiation Dosimetry

  1. Challenges in measuring absorbed dose with a simple open-to-atmosphere graphite calorimeter
    Alexandra Bourgouin* (Carleton University), Alexandra Bourgouin (Carleton University), Claudiu Cojocaru (NRC), Malcolm McEwen (National Research Council Canada)
  2. Developing a hybrid Pacemaker-Dosimeter to reduce the risk of pacemaker failure for patients receiving radiation therapy
    Amr Heikal (1)* ((1) Kingston General Hospital, Dept of Oncology, Queen's University), Amr Heikal (1, 3) ((1) Kingston General Hospital, Dept of Oncology, Queen's University), Catherine de Metz (1) ((2) Kingston General Hospital, Dept of Medicine, Queen's University), Damian Redfearn (2) ((3) Medical Physics Dept., Tom Baker Cancer Centre, Calgary AB), Andrew T. Kerr (1)
  3. Development of an alanine-based audit dosimetry system for Canada
    Iymad Mansour* (Carleton University ), Iymad Mansour (Carleton University ), Malcolm McEwen (National Research Council Canada)
  4. 3D dose verification for stereotactic lung and spine treatments using the EPID
    Peter McCowan* (CancerCare Manitoba), Peter McCowan (CancerCare Manitoba), Timothy vanBeek (CancerCare Manitoba), Eric van Uytven (CancerCare Manitoba), Boyd McCurdy (CancerCare Manitoba)
  5. Predicting correction factors for reference dosimetry in any phantom material for Leksell GammaKnife
    Lalageh Mirzakhanian* (McGill), Lalageh Mirzakhanian (McGill), Hamza Benmakhlouf ( Karolinska University Hospital), Jan Seuntjens (Cedars Cancer Centre)
  6. Characterization of two high-sensitivity dosimetry systems (MCP-N TLD and nanoDot OSLD) in the low energy X-ray domain
    Svetlana Kuznetsova* (University of Calgary, Physics and Astronomy Department), Svetlana Kuznetsova (University of Calgary, Physics and Astronomy Department), Yannick Poirier (University of Maryland School of Medicine, Department of Radiation Oncology), Jose Eduardo Villareal-Barajas (University of Calgary, Department of Oncology)
  7. Planar dosimetry with radiochromic hydrogel slabs
    Kevin Jordan* (London Regional Cancer Program/LHSC), Kevin Jordan (London Regional Cancer Program/LHSC)
  8. Application of the NRC primary standard water calorimeter to high-energy electron beams
    Bryan Muir* (National Research Council), Bryan Muir (National Research Council), Claudiu Cojocaru (National Research Council Canada), Malcolm McEwen (National Research Council Canada), Carl Ross (None)
  9. Experimental verification of 4D Monte Carlo calculations of dose delivered to a deforming anatomy
    Sara Gholampourkashi* (Carleton University), Sara Gholampourkashi (Carleton University), Joanna E. Cygler (The Ottawa Hospital Cancer Center), Bernie Lavigne (The Ottawa Hospital Cancer Center), Emily Heath (Carleton University)
  10. Clinical Implementation of On-line MOSFET in-Vivo Dosimetry for Single Fraction SBRT Lung Cancer Patients Treated with VMAT
    Ekaterina Tchistiakova* (Sunnybrook Health Sciences Centre / Odette Cancer Centre, Toronto, ON, Canada), Ekaterina Tchistiakova (Sunnybrook Health Sciences Centre / Odette Cancer Centre, Toronto, ON, Canada), Matt Wronski, Brian Keller
  11. The Canadian Primary Standard for Low Dose Rate Brachytherapy
    Hong Shen* (National Research Council Canada), Hong Shen (National Research Council Canada), Ernesto Mainegra-Hing, Malcolm McEwen, Carl Ross
  12. Heterogeneous multiscale simulations of gold nanoparticle radiotherapy considering intracellular nanoparticle distribution
    Martin Martinov* (Carleton University), Martin Martinov (Carleton University), Rowan Thomson (Carleton University)

14 July, 2017 - 11:00am: Session 4B - Diagnostic Imaging

  1. The Role of the Imaging Physicist in Implementing Three-Dimensional Printing for Surgical Applications
    Daniel Rickey* (CancerCare Manitoba), Daniel Rickey (CancerCare Manitoba), Tom Hayakawa (Health Sciences Centre), Richard Nason (Health Sciences Centre), Kevin Vint (Health Sciences Centre), Imran Ratanshi (Health Sciences Centre), Christian Petropolis (Health Sciences Centre), Michal Brichacek (Health Sciences Centre)
  2. CT Perfusion Imaging of the Liver during Hemodialysis: Assessment of Hepatic Blood Flow Distribution
    Raanan Marants [1]* ([1] Department of Medical Biophysics, Western University, London, ON), Raanan Marants [1] ([1] Department of Medical Biophysics, Western University, London, ON), Claire Grant [2] ([2] The Lilibeth Caberto Kidney Clinical Research Unit, Western University, London, ON [3] Division of Nephrology, London Health Sciences Centre, London, ON), Christopher McIntyre [1,2,3,4] ([4] Lawson Health Research Institute, London Health Sciences Centre, London, ON), Ting-Yim Lee [1,4,5] ([5] Robarts Research Institute, Western University, London, ON)
  3. Compliance to Excellence: Implementation of a Quality Control Program for Diagnostic Imaging Facilities
    Jeff Frimeth* (JF Medical Physics Inc.), Jeff Frimeth (JF Medical Physics Inc.)
  4. How should we target prostate tumours using fusion biopsy?
    Peter Martin* (Western University), Peter Martin (Western University), Derek Cool (Western University), Aaron Fenster (Robarts Research Institute), Aaron Ward (Western University)
  5. Towards Clinical Implementation of a Real-time Ultrasound-based Motion Compensation Algorithm
    Derek Gillies [1,2]* ([1] Robarts Research Institute; [2] Western University; [3] Centre for Imaging Technology Commercialization), Derek Gillies [1,2] ([1] Robarts Research Institute; [2] Western University; [3] Centre for Imaging Technology Commercialization), Lori Gardi [1,2], Shuang-ren Zhao [3], Aaron Fenster [1-3]
  6. The Role of the Medical Physicist in Drafting Radiation Protection Legislation
    Daniel Rickey* (CancerCare Manitoba), Daniel Rickey (CancerCare Manitoba), Ingvar Fife (CancerCare Manitoba)

14 July, 2017 - 2:00pm: Session 5A - Treatment Planning and Imaging in RT

  1. MV CBCT Reconstruction using a high-DQE Focused Cadmium Tungstate Detector
    Clay Lindsay* (British Columbia Cancer Agency), Clay Lindsay (British Columbia Cancer Agency), Magdalena Bazalova-Carter (University of Victoria), William Ansbacher (BCCA-Vancouver Island Centre)
  2. A simple model for optimal parotid sparing
    Marie-Pierre Milette* ((1) BC Cancer Agency-Southern Interior), Marie-Pierre Milette (1) ((1) BC Cancer Agency-Southern Interior), Sacha Walker (1)
  3. Initial experience with the VERO radiation therapy delivery system
    Ante Mestrovic* (BC Cancer Agency - Vancouver), Ante Mestrovic (BC Cancer Agency - Vancouver), Alanah M. Bergman (BC Cancer Agency-Vancouver), Ermias Gete (BC Cancer Agency-Vancouver)
  4. Implementation of VMAT in matRad, an open source treatment planning toolkit
    Eric Christiansen* (Carleton University), Eric Christiansen (Carleton University), Mark Bangert (German Cancer Research Centre DKFZ), Tong Xu (Carleton University), Emily Heath (Carleton University)
  5. Three years of 3D printed bolus: Clinical experience and recommendations
    Quinn Matthews* (BCCA - Centre for the North), Nick Chng (BCCA - Centre for the North), Quinn Matthews (BCCA - Centre for the North), Piotr Dubrowski (Stanford Cancer Centre), Nathan Smela (BCCA - Centre for the North), Narinder Sidhu (BCCA - Centre for the North)
  6. A Case for the Use of Flattening-Filter-Free 10 MV Beams for Pediatric Radiation Therapy
    Youssef Ben Bouchta* (British Columbia Cancer Agency - Vancouver Center), Youssef Ben Bouchta (British Columbia Cancer Agency - Vancouver Center), Alanah M. Bergman (BC Cancer Agency-Vancouver), Karen Goddard (BC Cancer Agency-Vancouver)
  7. Efficacy of Two Strategies for Adaptive Radiation Treatment of Prostate Bed
    Tim Craig* (Princess Margaret Hospital -UHN), Sandra Meyers (Princess Margaret Cancer Centre), Yazan Obeidi (Princess Margaret Cancer Centre), Cynthia Ménard (Centre Hospitalier de L’Université de Montréal), Peter Chung (Princess Margaret Cancer Centre), Padraig Warde (Princess Margaret Cancer Centre), Andrew McPartlin (Princess Margaret Cancer Centre), Melvin Chua (Princess Margaret Cancer Centre), Eve Tiong (Princess Margaret Cancer Centre), Alejandro Berlin (Princess Margaret Cancer Centre), Andrew Bayley (Princess Margaret Cancer Centre), Saibishkumar Parameswaran (Vancouver Island Centre), Charles Catton (Princess Margaret Cancer Centre), Tim Craig (Princess Margaret Hospital -UHN)
  8. Mixed modality radiation therapy optimisation using the column generation method
    Marc-Andre Renaud* (McGill University), Marc-Andre Renaud (McGill University), Monica Serban (McGill University Health Centre), Jan Seuntjens (McGill University)
  9. Characterization of a modern implementation of dynamic conformal arc therapy
    Lorcel Ericka Venturina* (Carleton University), Lorcel Ericka Venturina (Carleton University), Greg Fox (The Ottawa Hospital Cancer Centre), Elsayed Ali (The Ottawa Hospital Cancer Centre)
  10. Toward MR-only Radiotherapy Treatment Planning for Moving Targets
    Brige Chugh* (Sunnybrook Health Sciences Centre), Brige Chugh (Sunnybrook Health Sciences Centre), Shahad Al-Ward (Sunnybrook Health Sciences Centre), Abraam Soliman (Sunnybrook Health Sciences Centre), Arman Sarfehnia (Sunnybrook Health Sciences Centre), Anthony Kim (Sunnybrook Health Sciences Centre), Angus Lau (Sunnybrook Health Sciences Centre), Arjun Sahgal (Sunnybrook Health Sciences Centre), Greg Stanisz (Sunnybrook Health Sciences Centre), Brian Keller (Sunnybrook Health Sciences Centre)
  11. Gadolinium-based nanoparticles as contrast agents in CT
    Charmainne Cruje†‡* (†Robarts Research Institute, ‡Department of Medical Biophysics), Charmainne Cruje†‡ (†Robarts Research Institute, ‡Department of Medical Biophysics), David W. Holdsworth†‡, Elizabeth R. Gillies§|| (§Department of Chemistry, ||Department of Chemical and Biochemical Engineering, Western University, London, Ontario), Maria Drangova†‡
  12. VMAT treatment plan optimization using a noncoplanar class solution trajectory applied to cranial targets
    Joel Mullins* (McGill University), Joel Mullins (McGill University), François DeBlois (Jewish General Hospital), Jan Seuntjens (Cedars Cancer Centre)

14 July, 2017 - 2:00pm: Session 5B - Nuclear Medicine and MRI

  1. Optimized length of a calibration ion chamber for unsealed radionuclides
    Hans-Sonke Jans* (Cross Cancer Institute), Hans-Sonke Jans (Cross Cancer Institute, Edmonton, Alberta), Amir Keyvanloo (University of Miami, Florida)
  2. Help ensure traceability to Canadian national standards for radionuclide calibrators.
    Raphael Galea* (National Research Council of Canada), Raphael Galea (National Research Council of Canada), Samantha Eustace (CancerCare Manitoba), Geroge Mawko (QEII Health Sciences Centre)
  3. Monte Carlo simulations of the dosimetric properties of a novel glass microsphere for transarterial radioembolization
    Alasdair Syme* (1. Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada), Alasdair Syme 1 (1. Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada), Cody Church 2 (2. Dept of Physics and Atmospheric Science, Dalhousie University), George Mawko 1 (1. Department of Medical Physics, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada), JP Archambault 3 (3. National Research Council Canada), Robert Lewandowski 4 (4. Interventional Radiology, Northwestern University, Chicago, IL/US), David Liu 5 (5. Vancouver Imaging, Clinical Associate Professor, Faculty of Medicine, University of British Columbia, Vancouver BC Canada), Sharon Kehoe 6 (6. Department of Applied Oral Sciences, Dalhousie University, Halifax, Nova Scotia, Canada), Daniel Boyd 7 (7. Department of Applied Oral Sciences, Dalhousie University, Halifax, Nova Scotia, Canada), Robert Abraham 8 (8. Department of Diagnostic Imaging, Dalhousie University, Halifax, Nova Scotia, Canada)
  4. A Simulation Based Study of the Impact of the Inter-layer Scatter on Spatial Resolution in Dual-layer Offset Scintillation Arrays
    Mohammadreza Teimoorisichani* (Department of Physics and Astronomy/University of Manitoba), Mohammadreza Teimoorisichani (Department of Physics and Astronomy, University of Manitoba), Andrew Goertzen (Health Sciences Centre, University of Manitoba)
  5. Patient motion management using the positron emission tracking (PeTrack) algorithm in cardiac PET without time-of-flight.
    Spencer Manwell* (Carleton University), Spencer Manwell (Carleton University), Ran Klein (University of Ottawa, Division of Nuclear Medicine), Robert deKemp (University of Ottawa Heart Institute, Cardiac PET Centre), Tong Xu (Carleton University)
  6. Evaluation of double-sided adhesive tapes for scintillator coupling in positron emission tomography
    Devin Van Elburg* (University of Manitoba), Devin Van Elburg (University of Manitoba), Andrew Goertzen (Health Sciences Centre, University of Manitoba)
  7. Dual-spillover correction for SPECT myocardial blood flow measurement
    Glenn Wells* (University of Ottawa Heart Institute), Glenn Wells (University of Ottawa Heart Institute), Jennifer Renaud (University of Ottawa Heart Institute), Robert deKemp (University of Ottawa Heart Institute), Terrence Ruddy (University of Ottawa Heart Institute)
  8. Optimization of quantitative Tc(99m)- SPECT/CT acquisition and reconstruction parameters: a phantom study
    Simin Razavi* (The Ottawa Hospital), Simin Razavi (The Ottawa Hospital), Ran Klein (The Ottawa Hospital)
  9. Estimating the Transverse Relaxation Time of the 3.75 ppm Glutamate and Glutamine (Glx) Protons at 3 T
    Atiyah Yahya* (University of Alberta and Cross Cancer Institute), Karin Lypka (University of Alberta), Atiyah Yahya (University of Alberta and Cross Cancer Institute)
  10. Improving in vivo fat quantification using Magnetic Resonance Spectroscopy
    Clara Fallone* (University of Alberta), Clara Fallone (University of Alberta), Atiyah Yahya (Cross Cancer Institute and University of Alberta)
  11. Comparison of intravoxel incoherent motion and dynamic contrast-enhanced MRI perfusion in the human brain: initial experience.
    Nicholas Majtenyi* (Carleton University), Nicholas Majtenyi (Carleton University), Greg O. Cron (Medical Imaging, The Ottawa Hospital; The Ottawa Hospital Research Institute; Radiology, The University of Ottawa), Thanh B. Nguyen (Radiology, The Ottawa Hospital), Ian G. Cameron (Carleton University; Medical Imaging, The Ottawa Hospital; Radiology, The University of Ottawa)

15 July, 2017 - 11:00am: Session 6 - Brachytherapy

  1. Development of a 360° Transvaginal Ultrasound Needle Guidance System for Interstitial Gynecologic Brachytherapy
    Jessica Rodgers* (Robarts Research Institute, The University of Western Ontario), Jessica Rodgers (1) ((1) Biomedical Engineering Graduate Program, Western University; Robarts Research Institute, Western University), Jeffrey Bax (2) ((2) Robarts Research Institute, Western University, London, Ontario), Kathleen Surry (3) ((3) London Regional Cancer Program/LHSC), David D'Souza (4) ((4) London Regional Cancer Program/LHSC), Eric Leung (5) ((5) Odette Cancer Centre/Sunnybrook Health Sciences Centre), Aaron Fenster (6) ((6) Robarts Research Institute, Western University)
  2. Resolving Dosimetric Issues in Intravascular Brachytherapy
    Joseph DeCunha* (McGill Medical Physics Unit), Joseph DeCunha (McGill Medical Physics Unit), Shirin A. Enger (McGill University)
  3. Permanent Breast Seed Implants: Results from a 50-patient cohort
    Deidre Batchelar* (BC Cancer Agency - Southern Interior), Deidre Batchelar(1,2) ((1)BC Cancer Agency - Southern Interior), Marie-Pierre Milette(1,2) ((2)Department of Physics, University of British Columbia - Okanagan), Michelle Hilts(1,2), Juanita Crook(1)
  4. A Computational Model for Predicting Dose Escalation to the Dominant Intraprostatic Lesion During High Dose Rate Prostate Brachytherapy
    Matt Wronski* (Sunnybrook Odette Cancer Centre), Matt Wronski (Sunnybrook Odette Cancer Centre), Ananth Ravi, Melanie Davidson, Andrew Loblaw, Gerard Morton, Hans Chung, Chia-Lin Tseng, Lucas Mendez, Moti Paudel
  5. Development and Validation of a Novel Nomogram Model for HDR Prostate Brachytherapy
    Moti Paudel* (Sunnybrook Odette Cancer Centre), Moti Paudel (Sunnybrook Odette Cancer Centre, Toronto, ON, Canada), Ananth Ravi, Melanie Davidson, Gerard Morton, Andrew Loblaw, Hans Chung, Chia-Lin Tseng, Lucas Mendez, Matt Wronski
  6. Intra-operative use of a C-arm for quality assurance of low-dose-rate prostate brachytherapy
    Maryam Afsari Golshan* (BC Cancer Agency), Maryam Afsari Golshan (BC Cancer Agency), Ingrid Spadinger (BC Cancer Agency-Vancouver), Sara Mahdavi (BC Cancer Agency-Vancouver)
  7. Implementation and initial assessment of the Advanced Collapsed-cone Engine for ocular brachytherapy dosimetry
    Hali Morrison* (University of Alberta, Cross Cancer Institute), Hali Morrison (University of Alberta, Cross Cancer Institute), Geetha Menon (University of Alberta, Cross Cancer Institute), Matthew P. Larocque (University of Alberta, Cross Cancer Institute), Ezekiel Weis (University of Alberta, University of Calgary), Ron S. Sloboda (University of Alberta, Cross Cancer Institute)
  8. 3D Ultrasound Image Guidance for Permanent Seed Breast Brachytherapy: System Development and Benchtop Validation
    Justin Michael* (Imaging Research Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada; Biomedical Engineering Graduate Program, Western University, London, Ontario, Canada), Justin Michael (Imaging Research Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada; Biomedical Engineering Graduate Program, Western University, London, Ontario, Canada), Daniel Morton (Department of Medical Physics, BC Cancer Agency - Southern Interior, Kelowna, British Columbia, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada), Deidre Batchelar (Department of Medical Physics, BC Cancer Agency - Southern Interior, Kelowna, British Columbia, Canada), Michelle Hilts (Department of Medical Physics, BC Cancer Agency - Southern Interior, Kelowna, British Columbia, Canada; Department of Physics and Astronomy, University of Victoria, Victoria, British Columbia, Canada), Juanita Crook (Department of Radiation Oncology, BC Cancer Agency - Southern Interior, Kelowna, British Columbia, Canada), Aaron Fenster (Imaging Research Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada; Biomedical Engineering Graduate Program, Western University, London, Ontario, Canada; Departments of Medical Biophysics and Medical Imaging, Western Un)